Intracellular cGMP increase is not involved in thyroid cancer cell death

Intracellular cGMP increase is not involved in thyroid cancer cell death

Show other versions (1)

<h4>Introduction</h4> Type 5 phosphodiesterase (PDE5) inhibitors (PDE5i) lead to intracellular cyclic-guanosine monophosphate (cGMP) increase and are used for clinical treatment of erectile dysfunction. Studies found that cGMP may up/downregulate the growth of certain endocrine tumor cel...

Full description

Bibliographic Details
Main Authors: Sara D’ Alessandro, Elia Paradiso, Clara Lazzaretti, Samantha Sperduti, Carmela Perri, Francesco Antoniani, Sara Righi, Manuela Simoni, Giulia Brigante, Livio Casarini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062617/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062617/?tool=EBI

Similar Items